Results

Total Results: 613 records

Showing results for "how to do a case study".

141. Recommendation: Oral Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/oral-cancer-screening
     November 15, 2013 - A comprehensive examination of the oropharynx may require referral to a dental provider or specialist … Although there is interest in screening for oral HPV infection, medical and dental organizations do not … However, the subgroup analyses do not meet high-quality criteria. … The results of the overall study and the post hoc subgroup analysis do not provide sufficient evidence … How Does Evidence Fit With Biological Understanding?

142. 3W8Wr9Wwayaqujwmjo Bl- (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/3w8Wr9wwAyAqUJWmJo_bL-
     February 01, 2014 - Data were not available to determine the optimum age for testing and how the age at testing influ- ences … How- ever, how and when the benefit–harm ratio shifts for women facing this decision is uncertain. … findings and conclusions in this review are those of the authors, who are responsible for its content, and do … cancer for referral to a genetics center. … Family history of breast cancer: what do women understand and recall about their genetic risk?

143. Archived: Cost-Effectiveness Analyses of Population-Based Screening for Abdominal Aortic Aneurysm: Evidence Synthesis: Abdominal Aortic Aneurysm: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/cost-effectiveness-analyses-of-population-based-screening-for-abdominal-aortic-aneurysm-evidence-synthesis/abdominal-aortic-aneurysm-screening-february-2005
     February 15, 2005 - How will differences in treatment effectiveness affect cost-effectiveness estimates for AAA screening … Do effect measures capture preferences or utilities? … of a good quality rating to the MASS CEA. … How will differences in treatment effectiveness affect cost-effectiveness estimates for AAA screening … /QALY, although how much is uncertain.

144. ahrq29a - Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
     March 01, 2004 - How well does antiviral I. … How well does antiviral I, II-2. … How well do counseling II-3. … with chronic HCV infection, who frequently pass on antibodies to their children but usually do not pass … c) How well do counseling and immunizations in asymptomatic patients with HCV infection improve clinical

145. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/8dzfZ_s3tZueoEh5Xzh-3A
     July 26, 2016 - Case series or case reports were also included for identification of potential harms due to screening … Setting: Study was not conducted in a setting or country relevant to US primary care. … Fewer excisions were needed to detect a single case in older adults and in men. … physician re- view of patient-identified lesions and likely do not represent screen- ing populations … Diagnosing skin cancer in primary care: how do mainstream general practitioners compare with primary

146. Addendum to Screening for Ovarian Cancer: Evidence Update for the USPSTF Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/QtuWfedsMmUb_sAuKWdsGg
     December 31, 2014 - and conclusions in this document are those of the authors, who are responsible for its content, and do … conduct a bridge literature search in order to inform a reaffirmation statement on ovarian cancer … Mortality results were planned for a separate publication, although they do not appear to be available … Additionally, it was unclear how exclusion criteria were applied. … Vignette-based study of ovarian cancer screening: do U.S. physicians report adhering to evidence-based

147. Screening for Osteoporosis: An Update for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/RPB3rmcS9CK_eXPdzXSxZg
     July 01, 2010 - For osteo­ necrosis of the jaw, we included systematic reviews sum­ marizing evidence from case reports … Case reports of severe musculoskeletal pain that may be reversible after discontinuing the medication … Case reports of osteonecrosis of the jaw are primarily from patients with cancer who receive intravenous … The FDA has recently highlighted case reports of esophageal cancer and severe musculoskeletal pain. … Osteonecrosis of the jaw A report from the FDA described 151 case reports of osteonecrosis of the jaw

148. Archived: Evidence Summary: Preeclampsia: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/preeclampsia-screening-april-2017
     April 25, 2017 - How effectively do screening tests (eg, blood pressure, proteinuria) identify women with preeclampsia … a. How accurate are different screening tests for proteinuria? b. … , a model performance measure that refers to how well a model differentiates between persons with and … without the outcome. 27 f A model performance measure that refers to how well predicted risks compare … i A test performance statistic used to measure what proportion of patients who test negative do not

149. Screening Women for Intimate Partner Violence: A Systematic Review to Update teh 2004 USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/MjwZ4vRLZDVUSnfMA6SrDo
     June 01, 2012 - Clinicians could inquire about abuse during the clinic visit if there were indications to do so. … For women identified through screening with current, past, or increased risk for IPV, how well do interventions … well do interventions reduce exposure to IPV, physical or mental harms, or mortality? … How well the results of studies translate to clinical practice is also not clear, although most studies … For women identified through screening with current, past, or increased risk for IPV, how well do interventions

150. Let's Talk About It (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2024-04/breast-cancer-screening-lets-talk-about-it-final-rec-discussion-guide.pdf
     January 01, 2024 - breast cancer screening, including what age to start screening and how often people should be screened … These women should talk to their healthcare professional about how best to stay healthy. … include being told you might have cancer when you don’t—or being told you don’t have cancer when you do … More research is needed on how to better find breast cancer in women with dense breasts, whether that … How else can I reduce my risk of breast cancer?

151. Modeling Study: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-study/aspirin-to-prevent-cardiovascular-disease-preventive-medication
     April 26, 2022 - In the second, aspirin was initiated at a specific age with a plan to stop at a predefined age, specified … New Zealand population, 23 and it is not known how these rates compare with those for the US population … prevention aspirin trials, making it less clear how well the aspirin effects translate to these groups … The opinions expressed in this document are those of the authors and do not reflect the official position … ASCVD risk, % a 5 23.1 (15.8 to 30.4) 5.7 (0.0 to 11.3) −1.8 (−6.4 to 2.9) NA 7.5

152. Archived: Evidence Summary: Hepatitis C Virus Infection: Screening, 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
     March 08, 2004 - are few data regarding harms in patients who have false-positive tests or HCV-positive patients who do … How well do counseling and immunizations improve outcomes in asymptomatic patients with HCV infection … with chronic HCV infection, who frequently pass on antibodies to their children but usually do not pass … KQ 7: a) How well does antiviral treatment reduce the rate of viremia, improve aminotransferase levels … c) How well do counseling and immunizations in asymptomatic patients with HCV infection improve clinical

153. Archived: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening-2012
     May 15, 2012 - Additional Information Supporting Evidence and Research Taxonomy Related Resources & Tools How … How this cause-of-death adjudication process may affect estimates is unknown, but previous research has … How Does Evidence Fit With Biological Understanding? … do not outweigh the harms. … A large majority of the men who are being treated would do well without treatment.

154. Archived: Final Evidence Summary: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary16/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
     October 15, 2009 - Most studies use a hazard ratio (or other risk ratio) to measure how well a new risk factor predicts … how well the new risk factor reclassifies those who were assigned to the intermediate-risk group. … a Framingham risk score between 15% and 20%, but we do not know how many—a consistent but imprecise … Their report did not describe how they derived this estimate or how many intermediate-risk patients in … Some cohorts undoubtedly included intermediate-risk persons, but no analyses were done to determine how

155. Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/UPu84CV2CNuxR8kpVU6e3V
     November 01, 2008 - How- ever, it is important to consider the relative intensity of test use required to achieve those … per 10 000 Not varied Not varied * Data obtained from reference 29. † We assume that small adenomas do … However, because many adenomas do not progress to colorectal cancer before the person dies of other causes … The first adenoma occurs at a certain age and grows from a small to a medium to a large adenoma. … Individuals who do not have an underlying adenoma or preclinical cancer also face the risk for having

156. Archived: Final Evidence Summary: Intimate Partner Violence and Abuse of Elderly and Vulnerable Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary32/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening-2013
     May 08, 2012 - Clinicians could inquire about abuse during the clinic visit if there were indications to do so. … well do interventions reduce exposure to IPV, physical or mental harms, or mortality? … well do interventions reduce exposure to IPV, physical or mental harms, or mortality? … For women identified through screening with current, past, or increased risk for IPV, how well do interventions … for intimate partner violence, and how detection can lead to intervention.

157. Qd4Zm2Uk2Ldubpa9Yyfbrm (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Qd4Zm2Uk2LDuBPa9yyFBRM
     January 01, 2014 - Although there is interest in screening for oral HPV infection, medical and dental organizations do not … However, the subgroup analyses do not meet high-quality criteria. … The results of the overall study and the post hoc subgroup analysis do not provide sufficient evidence … base- line risk factors, possible lead- and length-time bias, and not reporting harms of screening or how … How Does Evidence Fit With Biological Understanding?

158. Recommendation: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening
     May 02, 2023 - Grade: B See “How to implement this recommendation” for additional information on adults at increased … How to implement this recommendation? … Persons with LTBI have no apparent symptoms, do not feel sick, cannot spread TB to others, and usually … Screening with an IGRA requires obtaining a single venous blood sample, and patients do not need to return … Evidence is needed to inform which populations should receive repeat screening for LTBI and how frequently

159. Draft Research Plan: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/brca-related-cancer-risk-assessment-genetic-counseling-testing
     January 18, 2024 - Share to Facebook Share to X Share to WhatsApp Share to Email … §Genetic testing may be done on the index patient, a relative with cancer, or a relative with highest … /2 mutations when performed by a nonspecialist in genetics in a clinical setting? … In women with pathogenic BRCA1/2 mutations, do interventions reduce the incidence of BRCA-related cancer … How does risk assessment for pathogenic BRCA1/2 mutations for women without BRCA1/2 -related cancer

160. Archived: Evidence Summary: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary17/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing-2013
     December 15, 2013 - Data were not available to determine the optimum age for testing and how the age at testing influences … However, how and when the benefit-harm ratio shifts for women facing this decision is uncertain. … How these factors influence patient decision making and eventual clinical outcomes is unknown. … Family history of breast cancer: what do women understand and recall about their genetic risk? … Do risk assessment, genetic counseling, and genetic testing lead to reduced incidence of BRCA-related